18F-Fluciclovine PET Detected Early Tumor Recurrence in Prostatectomy Bed With Low PSA of 0.3 ng/mL But Negative on 18F-PSMA PET Scan

被引:3
|
作者
Nguyen, Trinh T. [1 ]
Bhosale, Priya R. [2 ]
Lu, Yang [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Nucl Med, Div Diagnost Imaging, 1400 Pressler St, Unit1483, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Abdominal Imaging, Div Diagnost Imaging, Houston, TX USA
关键词
PSMA; PET/CT; fluciclovine; MRI; prostate cancer; metastasis; CANCER PATIENTS; RISING PSA;
D O I
10.1097/RLU.0000000000004356
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
A 58-year-old man with metastatic prostate cancer was treated with prostatectomy, radiation therapy to bone metastasis, and androgen deprivation therapy plus abiraterone. He had posttreatment nadir PSA of 0.1 ng/mL. A follow-up F-18-fluciclovine PET performed with PSA of 0.3 ng/mL showed a focal tracer-avid lesion in the left prostatectomy bed. This lesion was negative on F-18-DCFPyL PET/CT, but with typical MRI features for disease recurrence. Minimal urinary activity of fluciclovine helped detection of local disease recurrence in the prostatectomy bed.
引用
收藏
页码:69 / 70
页数:2
相关论文
共 50 条
  • [31] Incidental 18F-Fluciclovine Uptake in a Desmoid Tumor Detected in a Patient Undergoing PET/CT Imaging for Prostate Cancer
    Baiomy, Ali
    Jensen, Corey T.
    Ward, John F.
    Chasen, Beth A.
    Ravizzini, Gregory C.
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (04) : 355 - 357
  • [32] The Diagnostic Performance of 18F-PSMA-1007 PET/CT in Prostate Cancer Patients With Early Recurrence after Definitive Therapy with a PSA < 10 ng/ml
    Lengana, Thabo
    Lawal, Ismaheel
    Van Rensburg, Charl Janse
    Mokoala, Kgomotso
    Moshokoa, Evelyn
    Mazibuko, Sfiso
    Van de Wiele, Christophe
    Maes, Alex
    Vorster, Mariza
    Sathekge, Mike Machaba
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2022, 61 (02): : 120 - 129
  • [33] Pelvic Desmoplastic Small Round Cell Tumor on 18F-PSMA PET/CT
    Wang, Yuan
    Ding, Xiaohui
    Wang, Ruimin
    Liu, Yachao
    CLINICAL NUCLEAR MEDICINE, 2025, 50 (02) : 193 - 194
  • [34] Initial Institutional Experience with 18F-Fluciclovine PET-CT in Biochemical Recurrence of Prostate Cancer
    Farkas, Amy B.
    Green, Edward D.
    Thaggard, Anson L.
    Vijayakumar, Vani
    Henegan, John C.
    Lirette, Seth T.
    Nittala, Mary R.
    Vijayakumar, Srinivasan
    SOUTHERN MEDICAL JOURNAL, 2021, 114 (11) : 703 - 707
  • [35] [18F]DCFPyL PET/CT in detection and localization of recurrent prostate cancer following prostatectomy including low PSA < 0.5 ng/mL
    Perry, Elisa
    Talwar, Arpit
    Taubman, Kim
    Ng, Michael
    Wong, Lih-Ming
    Booth, Russell
    Sutherland, Tom R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (06) : 2038 - 2046
  • [36] Is There Any Role for 18F-Fluciclovine PET/CT in the Presence of Undetectable PSA in Prostate Cancer Patients After Definitive Treatment?
    Teyateeti, Ajalaya
    Teyateeti, Achiraya
    Macapinlac, Homer A.
    Lu, Yang
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (09) : 672 - 678
  • [37] Small Lymph Node Metastasis Detected by 68Ga-Prostate-Specific Membrane Antigen But Not 18F-Fluciclovine PET/CT in Low-Prostate-Specific Antigen Biochemical Recurrence of Prostate Cancer
    Chausse, Guillaume
    Abikhzer, Gad
    Probst, Stephan
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (04) : 250 - 251
  • [38] Assessing the effectiveness of MRI, 18 F-fluciclovine PET, SUV max , and PSA in detecting local recurrence of prostate cancer after prostatectomy
    Virarkar, Mayur K.
    Gruschkus, Stephen K.
    Ravizzini, Gregory C.
    Vulasala, Sai Swarupa R.
    Javadi, Sanaz
    Bhosale, Priya
    POLISH JOURNAL OF RADIOLOGY, 2024, 89 : e196 - e203
  • [39] A Prospective Head-to-Head Comparison of 18F-Fluciclovine With 68Ga-PSMA-11 in Biochemical Recurrence of Prostate Cancer in PET/CT
    Pernthaler, Birgit
    Kulnik, Roman
    Gstettner, Christian
    Salamon, Spela
    Aigner, Reingard M.
    Kvaternik, Herbert
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (10) : E566 - E573
  • [40] Application of 18F-PSMA-1007 PET/MR Imaging in Early Biochemical Recurrence of Prostate Cancer: Results of a Prospective Study of 60 Patients with Very Low PSA Levels=0.5 ng/mL
    Mojsak, Malgorzata
    Szumowski, Piotr
    Amelian, Anna
    Hladunski, Marcin
    Kubas, Bozena
    Mysliwiec, Janusz
    Kochanowicz, Jan
    Moniuszko, Marcin
    CANCERS, 2023, 15 (16)